Submucosal resection combined with lateral displacement is most effective at decreasing nasal obstruction caused by inferior turbinate hypertrophy
![](https://www.enttoday.org/wp-content/uploads/2014/11/ENT_pg04-01.png)
Submucosal resection combined with lateral displacement is most effective at decreasing nasal obstruction caused by inferior turbinate hypertrophy
What is the most reliable objective measurement for nasal patency assessment?
New therapeutic approaches to diagnosis, treatment discussed at American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) annual meeting
How well does real-time quaking-induced conversion (RT-QuIC) analysis of olfactory mucosa brushings discriminate between patients with sporadic Creutzfeldt–Jakob disease (CJD) and controls?
Guidelines to determine which patients are candidates for ESS when medical therapy fails
Does bevacizumab delivered as a submucosal and topical intranasal therapy effectively control hereditary hemorrhagic telangiectasia (HHT)-associated epistaxis?
How much is lost in annual productivity costs for a patient with refractory chronic rhinosinusitis (RCRS), and what is the relationship between productivity costs and RCRS-specific characteristics?
Evidence suggests admitting most patients to otolaryngology ward with continuous pulse oximetry
Could a nasal spray of engineered proteins be used as front-line prophylactic defense against the influenza infection and provide a new way to prevent infection of current and emerging influenza […]